NASDAQ:CBIO
$0.295
(
-2.99%
)
Friday, 27th Jan 2023
Catalyst Biosciences Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.195 | $0.650 | Friday, 27th Jan 2023 CBIO stock ended at $0.295. This is 2.99% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 10.34% from a day low at $0.290 to a day high of $0.320. |
| 90 days | $0.195 | $0.650 | |
| 52 weeks | $0.195 | $2.09 |
Historical Catalyst Biosciences prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $0.312 | $0.320 | $0.290 | $0.295 | 570 480 |
| 2023-01-26 | $0.305 | $0.320 | $0.300 | $0.304 | 394 381 |
| 2023-01-25 | $0.320 | $0.320 | $0.300 | $0.300 | 794 862 |
| 2023-01-24 | $0.278 | $0.320 | $0.274 | $0.297 | 3 060 244 |
| 2023-01-23 | $0.270 | $0.283 | $0.260 | $0.270 | 1 509 613 |
| 2023-01-20 | $0.260 | $0.275 | $0.250 | $0.267 | 1 332 018 |
| 2023-01-19 | $0.260 | $0.260 | $0.240 | $0.250 | 648 100 |
| 2023-01-18 | $0.260 | $0.265 | $0.250 | $0.250 | 1 337 008 |
| 2023-01-17 | $0.270 | $0.280 | $0.250 | $0.250 | 2 672 300 |
| 2023-01-13 | $0.275 | $0.290 | $0.195 | $0.263 | 18 049 291 |
| 2023-01-12 | $0.610 | $0.640 | $0.610 | $0.630 | 974 900 |
| 2023-01-11 | $0.600 | $0.630 | $0.600 | $0.620 | 619 600 |
| 2023-01-10 | $0.640 | $0.640 | $0.603 | $0.607 | 1 037 140 |
| 2023-01-09 | $0.640 | $0.650 | $0.630 | $0.630 | 469 500 |
| 2023-01-06 | $0.600 | $0.650 | $0.600 | $0.640 | 1 008 300 |
| 2023-01-05 | $0.600 | $0.605 | $0.590 | $0.600 | 230 691 |
| 2023-01-04 | $0.594 | $0.610 | $0.560 | $0.600 | 1 034 201 |
| 2023-01-03 | $0.566 | $0.590 | $0.540 | $0.585 | 685 503 |
| 2022-12-30 | $0.577 | $0.600 | $0.496 | $0.528 | 1 871 130 |
| 2022-12-29 | $0.540 | $0.580 | $0.530 | $0.545 | 1 638 666 |
| 2022-12-28 | $0.520 | $0.540 | $0.510 | $0.520 | 1 474 244 |
| 2022-12-27 | $0.540 | $0.550 | $0.501 | $0.512 | 1 413 912 |
| 2022-12-23 | $0.500 | $0.510 | $0.490 | $0.503 | 278 923 |
| 2022-12-22 | $0.496 | $0.510 | $0.488 | $0.488 | 361 213 |
| 2022-12-21 | $0.523 | $0.523 | $0.495 | $0.500 | 721 938 |
| 2022-12-20 | $0.491 | $0.512 | $0.490 | $0.496 | 940 181 |
| 2022-12-19 | $0.493 | $0.510 | $0.490 | $0.491 | 116 267 |
| 2022-12-16 | $0.480 | $0.500 | $0.480 | $0.498 | 201 482 |
| 2022-12-15 | $0.492 | $0.520 | $0.490 | $0.490 | 270 636 |
| 2022-12-14 | $0.501 | $0.520 | $0.490 | $0.492 | 724 566 |
| 2022-12-13 | $0.510 | $0.527 | $0.481 | $0.502 | 308 452 |
| 2022-12-12 | $0.511 | $0.521 | $0.506 | $0.510 | 187 769 |
| 2022-12-09 | $0.521 | $0.540 | $0.502 | $0.510 | 510 235 |
| 2022-12-08 | $0.540 | $0.550 | $0.514 | $0.521 | 586 857 |
| 2022-12-07 | $0.531 | $0.545 | $0.520 | $0.532 | 58 405 |
| 2022-12-06 | $0.550 | $0.560 | $0.521 | $0.537 | 204 106 |
| 2022-12-05 | $0.545 | $0.560 | $0.545 | $0.550 | 310 195 |
| 2022-12-02 | $0.550 | $0.558 | $0.550 | $0.550 | 135 759 |
| 2022-12-01 | $0.550 | $0.560 | $0.546 | $0.550 | 77 180 |
| 2022-11-30 | $0.550 | $0.560 | $0.549 | $0.558 | 46 517 |
| 2022-11-29 | $0.550 | $0.560 | $0.540 | $0.550 | 52 298 |
| 2022-11-28 | $0.550 | $0.561 | $0.541 | $0.550 | 70 574 |
| 2022-11-25 | $0.558 | $0.561 | $0.545 | $0.550 | 10 330 |
| 2022-11-23 | $0.550 | $0.561 | $0.540 | $0.555 | 78 734 |
| 2022-11-22 | $0.542 | $0.570 | $0.542 | $0.550 | 76 236 |
| 2022-11-21 | $0.556 | $0.575 | $0.542 | $0.542 | 183 404 |
| 2022-11-18 | $0.555 | $0.570 | $0.542 | $0.566 | 34 466 |
| 2022-11-17 | $0.570 | $0.571 | $0.540 | $0.552 | 115 387 |
| 2022-11-16 | $0.554 | $0.566 | $0.540 | $0.560 | 56 744 |
| 2022-11-15 | $0.550 | $0.575 | $0.540 | $0.545 | 121 419 |
About Catalyst Biosciences
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);... CBIO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
